NO20080182L - Substituerte fenylfosfater, som feller promedikamenter av steroider og beta-agonister, for behandling av lungeinflammasjon og bronkiesammentrekning - Google Patents
Substituerte fenylfosfater, som feller promedikamenter av steroider og beta-agonister, for behandling av lungeinflammasjon og bronkiesammentrekningInfo
- Publication number
- NO20080182L NO20080182L NO20080182A NO20080182A NO20080182L NO 20080182 L NO20080182 L NO 20080182L NO 20080182 A NO20080182 A NO 20080182A NO 20080182 A NO20080182 A NO 20080182A NO 20080182 L NO20080182 L NO 20080182L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- pneumonia
- prodrugs
- steroids
- precipitate
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title abstract 3
- 239000000651 prodrug Substances 0.000 title abstract 3
- 206010035664 Pneumonia Diseases 0.000 title abstract 2
- 229940125388 beta agonist Drugs 0.000 title abstract 2
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical class OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 title abstract 2
- 230000008602 contraction Effects 0.000 title 1
- 239000002244 precipitate Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- 206010006482 Bronchospasm Diseases 0.000 abstract 2
- 230000007885 bronchoconstriction Effects 0.000 abstract 2
- 206010068956 Respiratory tract inflammation Diseases 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 238000012387 aerosolization Methods 0.000 abstract 1
- 238000000889 atomisation Methods 0.000 abstract 1
- 239000003246 corticosteroid Substances 0.000 abstract 1
- 229940112141 dry powder inhaler Drugs 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69054505P | 2005-06-14 | 2005-06-14 | |
PCT/US2006/022790 WO2006138212A1 (en) | 2005-06-14 | 2006-06-12 | SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PRODRUGS OF STEROIDS AND β -AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080182L true NO20080182L (no) | 2008-02-21 |
Family
ID=37570763
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080182A NO20080182L (no) | 2005-06-14 | 2008-01-11 | Substituerte fenylfosfater, som feller promedikamenter av steroider og beta-agonister, for behandling av lungeinflammasjon og bronkiesammentrekning |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100209508A1 (es) |
EP (1) | EP1893220A4 (es) |
JP (1) | JP2008546694A (es) |
KR (1) | KR20060130515A (es) |
CN (1) | CN101227912A (es) |
AR (1) | AR054475A1 (es) |
AU (1) | AU2006259604A1 (es) |
BR (1) | BRPI0611567A2 (es) |
CA (1) | CA2612364A1 (es) |
IL (1) | IL187816A0 (es) |
NO (1) | NO20080182L (es) |
RU (1) | RU2008100237A (es) |
TW (1) | TW200718707A (es) |
WO (1) | WO2006138212A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8158780B2 (en) | 2006-09-19 | 2012-04-17 | Cipla Limited | Processes for the preparation of ciclesonide and its crystal modification |
JP2010513277A (ja) * | 2006-12-13 | 2010-04-30 | ギリード・サイエンシズ・インコーポレーテッド | COPDおよび慢性気管支炎の治療のためのムスカリン受容体アンタゴニストおよびβ−アゴニストの共通プロドラッグとしてのモノホスフェート |
JP2010513276A (ja) * | 2006-12-13 | 2010-04-30 | ギリード・サイエンシズ・インコーポレーテッド | 肺炎症および気管支収縮の治療のための抗炎症シグナル伝達モジュレーター(AISTM)およびβ−アゴニストの相互プロドラッグとしてのモノホスフェート |
US8524697B2 (en) | 2007-12-21 | 2013-09-03 | Merck Sharp & Dohme Corp. | C20-C21 substituted glucocorticoid receptor agonists |
WO2009085880A2 (en) * | 2007-12-21 | 2009-07-09 | Schering Corporation | C-21 thioethers as glucocorticoid receptor agonists |
AR074148A1 (es) * | 2008-06-10 | 2010-12-29 | Gilead Sciences Inc | Derivados de corticoesteroides beta agonistas fosforilados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades del aparato respiratorio |
WO2010126953A1 (en) * | 2009-04-29 | 2010-11-04 | Gilead Sciences, Inc. | Corticosteroid linked beta-agonist compounds for use in therapy |
WO2010132743A1 (en) * | 2009-05-15 | 2010-11-18 | Gilead Sciences, Inc. | Corticosteroid beta-agonist compounds for use in therapy |
US20120171126A1 (en) * | 2009-06-16 | 2012-07-05 | Purakkattle Biju J | NOVEL [3,2-c] HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS COMPOSITIONS AND USES THEREOF |
ME01331B (me) * | 2009-09-11 | 2013-12-20 | Chiesi Farm Spa | Derivati izoksazolidina |
WO2011081937A1 (en) | 2009-12-15 | 2011-07-07 | Gilead Sciences, Inc. | Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy |
JP6124176B2 (ja) * | 2013-03-26 | 2017-05-10 | 株式会社伏見製薬所 | 樹脂成形体用組成物 |
CN104510726A (zh) * | 2013-09-27 | 2015-04-15 | 张金华 | 一种用于清洁呼吸道系统的食盐干粉吸入剂 |
PT107567B (pt) * | 2014-03-31 | 2019-02-13 | Hovione Farm S A | Secador por atomização com atomizador múltiplo, método para o aumento de escala de pós para inalação secos por dispositivo de atomização múltiplo e uso de vários atomizadores num secador por atomização |
BR112018074922B1 (pt) | 2016-06-02 | 2022-10-25 | Abbvie Inc | Compostos agonistas de receptores de glucocorticoides, composição farmacêutica compreendendo ditos compostos e uso terapêutico dos mesmos |
MX2019005330A (es) * | 2016-11-08 | 2019-09-11 | Regeneron Pharma | Esteroides y conjugados de proteinas de los mismos. |
EP3624894A1 (en) | 2017-05-18 | 2020-03-25 | Regeneron Pharmaceuticals, Inc. | Cyclodextrin protein drug conjugates |
RS61994B1 (sr) | 2017-12-01 | 2021-07-30 | Abbvie Inc | Agonist glukokortikoidnog receptora i njegovi imunokonjugati |
KR20200108002A (ko) | 2018-01-08 | 2020-09-16 | 리제너론 파마슈티칼스 인코포레이티드 | 스테로이드 및 이의 항체-접합체 |
US11377502B2 (en) | 2018-05-09 | 2022-07-05 | Regeneron Pharmaceuticals, Inc. | Anti-MSR1 antibodies and methods of use thereof |
IT201900014178A1 (it) * | 2019-08-06 | 2021-02-06 | Genetic S P A | Esteri del montelukast e loro formulazioni farmaceutiche |
CN112592280B (zh) * | 2020-12-09 | 2023-05-23 | 青岛职业技术学院 | 一种消旋沙丁胺醇的制备方法 |
TW202304462A (zh) | 2021-03-23 | 2023-02-01 | 美商美國禮來大藥廠 | 糖皮質素受體激動劑 |
AR125079A1 (es) | 2021-03-23 | 2023-06-07 | Lilly Co Eli | Agonistas de receptores de glucocorticoides sustituidos con carboxi |
JP2024523545A (ja) * | 2021-06-24 | 2024-06-28 | 江蘇先声薬業有限公司 | ステロイド系化合物、その医薬組成物及びその応用 |
WO2023040793A1 (zh) * | 2021-09-14 | 2023-03-23 | 映恩生物制药(苏州)有限公司 | 一种抗炎症的化合物及其用途 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE585432A (fr) * | 1958-12-08 | 1960-06-08 | American Cyanamid Co | Stéroïdes fluorés. |
US4757079A (en) * | 1986-06-24 | 1988-07-12 | Dynamac Corporaton | Anti-hypertensive piperidine compounds |
GR1001529B (el) * | 1990-09-07 | 1994-03-31 | Elmuquimica Farm Sl | Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης. |
ES2124884T3 (es) * | 1993-04-02 | 1999-02-16 | Byk Gulden Lomberg Chem Fab | Nuevos derivados de prednisolona. |
US6300326B1 (en) * | 1994-11-02 | 2001-10-09 | Michael R. Dobbs | Composition and method for control and treatment of cutaneous inflammation |
IT1303671B1 (it) * | 1998-07-28 | 2001-02-23 | Nicox Sa | Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio |
WO2004103379A1 (en) * | 2003-05-22 | 2004-12-02 | Altana Pharma Ag | Salmeterol and ciclesonide combination |
WO2005028495A1 (en) * | 2003-09-24 | 2005-03-31 | Glaxo Group Limited | Anti-inflammatory glucocorticoids |
WO2005063777A1 (en) * | 2003-12-23 | 2005-07-14 | Corus Pharma | Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation |
-
2006
- 2006-06-12 CA CA002612364A patent/CA2612364A1/en not_active Abandoned
- 2006-06-12 JP JP2008516976A patent/JP2008546694A/ja active Pending
- 2006-06-12 WO PCT/US2006/022790 patent/WO2006138212A1/en active Application Filing
- 2006-06-12 BR BRPI0611567A patent/BRPI0611567A2/pt not_active IP Right Cessation
- 2006-06-12 AU AU2006259604A patent/AU2006259604A1/en not_active Abandoned
- 2006-06-12 RU RU2008100237/04A patent/RU2008100237A/ru not_active Application Discontinuation
- 2006-06-12 US US11/922,258 patent/US20100209508A1/en not_active Abandoned
- 2006-06-12 EP EP06784777A patent/EP1893220A4/en not_active Withdrawn
- 2006-06-12 CN CNA2006800213783A patent/CN101227912A/zh active Pending
- 2006-06-14 AR ARP060102527A patent/AR054475A1/es unknown
- 2006-06-14 TW TW095121230A patent/TW200718707A/zh unknown
- 2006-06-14 KR KR1020060053519A patent/KR20060130515A/ko not_active Application Discontinuation
-
2007
- 2007-12-02 IL IL187816A patent/IL187816A0/en unknown
-
2008
- 2008-01-11 NO NO20080182A patent/NO20080182L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2008546694A (ja) | 2008-12-25 |
BRPI0611567A2 (pt) | 2016-11-16 |
CA2612364A1 (en) | 2006-12-28 |
EP1893220A4 (en) | 2011-06-15 |
IL187816A0 (en) | 2008-08-07 |
RU2008100237A (ru) | 2009-07-20 |
WO2006138212A1 (en) | 2006-12-28 |
EP1893220A1 (en) | 2008-03-05 |
AR054475A1 (es) | 2007-06-27 |
AU2006259604A1 (en) | 2006-12-28 |
TW200718707A (en) | 2007-05-16 |
KR20060130515A (ko) | 2006-12-19 |
CN101227912A (zh) | 2008-07-23 |
US20100209508A1 (en) | 2010-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080182L (no) | Substituerte fenylfosfater, som feller promedikamenter av steroider og beta-agonister, for behandling av lungeinflammasjon og bronkiesammentrekning | |
NO20061254L (no) | Farmasoytiske blandinger | |
WO2005063777A8 (en) | Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation | |
WO2009086470A3 (en) | Aerosolized nitrite and nitric oxide - donating compounds and uses thereof | |
HRP20130052T1 (hr) | Lijeäśenje respiratorne bolesti | |
WO2012047674A3 (en) | Methods and compositions for disease treatment using inhalation | |
NO20076561L (no) | Imidazoquinoliner som lipid kinaseinhibitorer | |
BR112012023578A2 (pt) | derivado de piridina e pirazina para o tratamento de cf | |
WO2012031603A3 (en) | Airway administration of angiogenesis inhibitors | |
CA2905975A1 (en) | Methods for treating respiratory diseases and formulations therefor | |
WO2011141929A3 (en) | Aqueous pharmaceutical compositions of fluticasone and olopatadine | |
RS54241B1 (en) | INHALATION COMPONENT CONTAINING ACLIDINIUM FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE | |
WO2009099998A3 (en) | Therapeutic treatment for lung conditions | |
SG10201806681YA (en) | Amide compound and use thereof as agent for the treatment and prevention of diseases caused by rna- and/or dna-containing viruses, and concomitant diseases | |
Prabhu et al. | Inhibition of metastatic lung cancer in C57BL/6 mice by marine mangrove Rhizophora apiculata | |
MX2020007971A (es) | Composiciones y metodos para tratar edema pulmonar o inflamacion pulmonar. | |
BR112012000101B8 (pt) | carboidratos medicinais para tratamento de condições respiratórias | |
MX2009013926A (es) | Compuestos de etinilindol. | |
WO2016004395A1 (en) | Sore-throat compositions and related methods | |
BR112012030930A2 (pt) | fatores de trevo (tff) para tratamento de doenças pulmonares crônicas. | |
WO2006136962A3 (en) | Airway administration of tissue factor pathway inhibitor in inflammatory conditons affecting the respiratory tract | |
CN111065386A (zh) | 减轻肺部感染的方法 | |
BRPI0413968A (pt) | composto de anel condensado e seu uso | |
WO2008076269A3 (en) | MONOPHOSPHATES AS MUTUAL PRODRUGS OF MUSCARINIC RECEPTOR ANTAGONISTS AND β-AGONISTS FOR THE TREATMENT OF COPD AND CHRONIC BRONCHITIS | |
van der Velden et al. | Airway Remodeling In House Dust Mite-Induced Allergic Airway Disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |